Subscribe
Funding & M&A
4 min read

A profitable treat brand is raising from the crowd, not a VC

Profitable treat brand Farm to Pet is raising up to $1.24M from its own customers on StartEngine at a $24M valuation.

Written by
The Underbite
Published on
June 30, 2026
A profitable treat brand is raising from the crowd, not a VC

Most pet brands that grow 186% a year end up in a venture round or an acquisition. Farm to Pet is doing something less common: it turned profitable, then opened the next raise to its own customers on StartEngine. The choice says as much about the funding market for consumer pet brands as it does about the company.

Farm to Pet opens a Reg CF round on the back of $5M in revenue

The single-ingredient treat maker launched its first Regulation Crowdfunding campaign on StartEngine, timed to its fifth anniversary.

The numbers behind it are real. Farm to Pet grew from roughly $80,000 in first-year sales in 2021 to more than $5 million in revenue in 2025, a compound annual growth rate above 186%. The company says it became profitable in 2026.

It reports more than 250,000 customers and 650 retail partners. Its core product is a 100% single-ingredient chicken treat, human-grade protein, made in small batches.

The raise is structured as Reg CF with a $20,000 minimum and a maximum of about $1.24 million, at a stated $24 million valuation. Proceeds are earmarked for production capacity, wholesale expansion, product development, and customer acquisition.

Why a profitable brand chooses the crowd over a VC

A company growing this fast and turning profitable would normally have its pick of institutional money. Choosing Reg CF is a strategic signal, and it cuts in a few directions.

Profitability changes the leverage

A brand that does not need to raise can raise on its own terms. Farm to Pet is not selling control to a fund, it is selling small stakes to customers while keeping the cap table founder-friendly. For bootstrapped operators, that optionality is the whole point of getting to profitability early.

The customers are the campaign

A 250,000-person customer base is a built-in investor pool and a marketing channel. Reg CF turns loyal buyers into shareholders who then have a financial reason to evangelize. For a CPG brand fighting for shelf and repeat purchase, that flywheel can be worth more than the cash.

The valuation will get scrutinized

A $24 million valuation on $5 million of revenue is a roughly 5x revenue ask in a crowdfunding wrapper. That is rich for a treat brand, and it is the figure prospective investors and operators should pressure-test. Crowdfunding lets a company set its own number in a way a priced institutional round rarely would.

The broader read for the category: functional and single-ingredient treats remain one of the most fundable corners of pet, but the capital is getting more creative. When a profitable brand skips the VC route, it signals both confidence and a recognition that traditional pet-CPG venture money is selective right now.

Whether crowd capital becomes a real path for pet CPG

The campaign's outcome is a small data point with an outsized read. If Farm to Pet fills a seven-figure raise from its own customers at a premium valuation, it strengthens the case that profitable DTC pet brands can fund expansion without surrendering equity to a fund.

Watch the raise velocity and the final amount against that $1.24 million ceiling, and watch whether the production-capacity and wholesale spend actually translates into shelf gains over the next year. A 186% growth rate is hard to sustain as the base gets larger, and the next phase is about holding margin while scaling distribution.

For operators weighing how to fund their own next chapter, Farm to Pet is a live experiment in raising from the people who already buy the product.

Source: Farm to Pet crowdfunding via Business Wire. Campaign terms via Kingscrowd

Subscribe to newsletter

Join our newsletter to stay up to date on features and releases.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

What's Happening

Other News

More stories shaping the pet industry this week. From funding rounds and product launches to regulatory shifts and retail strategy, stay ahead of what's driving the market.

Read article
Vetspire Splits From Thrive, Lands a Battery Ventures Backing
Funding & M&A
4 min read

Vetspire Splits From Thrive, Lands a Battery Ventures Backing

Vetspire has spun out of Thrive Pet Healthcare's orbit with a growth investment from Battery Ventures and a new CEO, Zachary Seely. The AI-powered practice management platform, used by more than 800 veterinary hospitals and clinics, will operate independently while Thrive remains a customer. The deal tests whether AI-native vet software can draw institutional capital without a strategic parent underwriting it.

Read article
Read article
PetMeds Revenue Falls 20% as Takeover Fight Drags On
Earnings
6 min read

PetMeds Revenue Falls 20% as Takeover Fight Drags On

PetMeds' first-quarter revenue fell 19.9% to $41.0 million and cash reserves dropped to $13.1 million, even as the company narrowed its net loss to $6.1 million from $34.2 million a year earlier. The results land as an unsolicited $3-a-share buyout offer from SilverCape Investments remains on the table and a $37 million sale-leaseback of its headquarters awaits closing.

Read article
Read article
FDA Clears Zoetis Drug for Screwworm as Outbreak Spreads North
Regulatory
4 min read

FDA Clears Zoetis Drug for Screwworm as Outbreak Spreads North

The FDA granted Zoetis an emergency use authorization for Simparica Trio to treat New World screwworm in dogs, the first product cleared specifically for the threat. Texas has already begun requiring treatment before dogs cross certain lines, putting boarding facilities, transporters, and border-state vet practices under a new compliance mandate.

Read article
View all articles